Abrocitinib therapy effective in patients with Atopic dermatitis: Study Jacinthlyn Sylvia8 July 2024 5:15 AM ISTA new study published in the International Journal of Dermatology suggests that abrocitinib is an effective therapy for atopic dermatitis (AD) since...
Berberine could treat eczema-exacerbated staph infections, suggests study Dr. Kamal Kant Kohli27 Jun 2024 8:00 PM ISTAtlanta: Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide.Eczema is associated with an altered...
JnJ completes acquisition of Proteologix Ruchika Sharma23 Jun 2024 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held...
Crisaborole may Sustain Effective Control in Atopic Dermatitis, finds study Jacinthlyn Sylvia21 Jun 2024 6:30 AM ISTManaging atopic dermatitis (AD) often proves to be a persistent challenge in dermatological practice, with treatments frequently falling short in...
FDA approves single dose autoinjector for atopic dermatitis Dr. Kamal Kant Kohli14 Jun 2024 7:45 PM ISTThe US food and Drug Administration has approved a new 300 mg single-dose autoinjector for tralokinumab-ldrm (Adbry) for adults with...
Can high sodium diet increase risk of eczema? Dr. Kamal Kant Kohli6 Jun 2024 9:00 PM ISTUCSF Study finds that changes in daily salt intake may explain eczema flares. A high sodium diet may increase the risk of eczema, according to...
Upadacitinib Outperforms Dupilumab in Treating Atopic Dermatitis: Study Dr Riya Dave4 Jun 2024 8:00 PM ISTResearchers have found that upadacitinib (Rinvoq) was more effective than dupilumab (Dupixent) in treating moderate-to-severe atopic dermatitis in a...
JnJ to buy rights to Numab Therapeutics Clinical-Stage Bispecific Antibody NM26 Ruchika Sharma29 May 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage...
Johnson & Johnson to acquire Proteologix for USD 850 million in cash Ruchika Sharma20 May 2024 4:23 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held...
Submit preliminary analysis of primary data of subjects above 18 years in India: CDSCO Panel Tells Sanofi on Amlitelimab study Dr. Divya Colin19 May 2024 6:00 PM ISTNew Delhi: After considering the phase III clinical study protocol of the monoclonal antibody Amlitelimab in the treatment of moderate-to-severe...
A tailored vaccine could one day treat eczema in children-new research Dr. Kamal Kant Kohli17 May 2024 8:45 PM ISTNew research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven...
Higher number of biologics required for control of coexisting PsA and atopic dermatitis: Study Jacinthlyn Sylvia13 May 2024 6:45 AM ISTA recent study published in the Journal of Personalized Medicine observed new insights regarding the treatment of psoriatic arthritis (PsA) and its...
